Skip to main content
Clinical Trials/NCT06282328
NCT06282328CompletedNot Applicable

HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting: A Monocentric Observational Cross-Sectional Study

Castagna Antonella1 site in 1 country300 target enrollmentStarted: February 14, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
Prevalence of HIV infection

Study Overview

Brief Summary

This study aims to evaluate the prevalence of previously undiagnosed HIV infection in the hospital setting (across various medical or surgical departments) among individuals exhibiting at least one HIV indicator condition (HIV-IC) and/or engaging in risky behaviors.

This is a cross-sectional, single-center study with additional procedures. Data collection will involve clinical and laboratory data from individuals with at least one HIV-IC and/or behavioral risk factor for HIV infection admitted to the San Raffaele Hospital in Milan for any reason.

The overall study duration is 24 months, with recruitment lasting 20 months. Individuals will be actively recruited from various medical or surgical units of the hospital. After obtaining informed consent, clinical and laboratory information related to the study will be collected, along with specific blood samples. The presence of at least one HIV-IC will be determined using available clinical, radiological, and laboratory parameters during hospitalization.

Following informed consent, hospitalized individuals will complete a paper questionnaire, aimed at identifying behavioral risk factors for HIV infection. If at least one HIV-IC or behavioral risk factor is present, the person will be eligible for inclusion in the clinical study, and a rapid capillary HIV test will be conducted bedside.

In case of a positive rapid capillary HIV test result, antigen/antibody testing and Western Blot for HIV confirmation will be performed on venous blood samples on the same day.

Detailed Description

Study Objective:

This study aims to evaluate the prevalence of previously undiagnosed HIV infection in the hospital setting (across various medical or surgical departments) among individuals exhibiting at least one HIV indicator condition (HIV-IC) and/or engaging in risky behaviors.

Study Design:

This is a cross-sectional, single-center study with additional procedures. Data collection will involve clinical and laboratory data from individuals with at least one HIV-IC and/or behavioral risk factor for HIV infection admitted to the San Raffaele Hospital in Milan for any reason.

Study Duration:

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
14 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Individuals admitted to various Units of IRCCS San Raffaele Hospital.
  • Individuals aged 14 years or older.
  • Individuals meeting at least one of the following criteria:
  • Presence of at least one HIV-IC.
  • Presence of at least one behavioral risk factors for HIV infection.
  • Individuals providing specific written informed consent for the study, or minors whose parents or legal guardians provide specific written informed consent for the study.

Exclusion Criteria

  • Individuals not providing specific written informed consent for the study.
  • Individuals with previously known HIV infection.

Outcomes

Primary Outcomes

Prevalence of HIV infection

Time Frame: Month 20

The primary objective of the study is to estimate the prevalence of previously unknown HIV infection (new HIV infection) in the hospital setting among individuals exhibiting at least one HIV indicator condition (HIV-IC) and/or with presence of behavioral risk factors

Secondary Outcomes

  • Number of Behavioral Risk Factors(Month 20)
  • CD4+ lymphocytes(Month 20)
  • Number of HIV-IC(Month 20)
  • HIV-RNA(Month 20)

Investigators

Sponsor
Castagna Antonella
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Castagna Antonella

Prof

IRCCS San Raffaele

Study Sites (1)

Loading locations...

Similar Trials